Back to Trades
Total Value
$1.9M
Net $1.4M sold
Filing Date
Jul 10, 2026
3 transactions
Sales
$1.4M
3 transactions
Trade Summary
On Jul 8, 2026, Czibere Akos, Insider, sold $1.9M of Aktis Oncology, Inc. (AKTS) across 3 transactions. The filing covers Common Stock and reflects net selling of $1.4M. Reported prices ranged from $4.95 to $28.71. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Aktis Oncology, Inc.
- Ticker Symbol
- AKTS
- CIK
- 0002035832
Insider Information
- Name
- Czibere Akos
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001193125-26-300162
- Form Type
- 4
- Net Trading Amount
- -$1.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 50,000 | $4.95 | Exercise | $247.5K |
| Jul 8, 2026 | Common Stock | 14,800 | $27.13 | Sale | $401.5K |
| Jul 8, 2026 | Common Stock | 30,829 | $27.95 | Sale | $861.7K |
| Jul 8, 2026 | Common Stock | 4,371 | $28.71 | Sale | $125.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | AKTS derivative | 50,000 | $4.95 | Exercise | $247.5K |
Want live alerts when Czibere Akos trades again?
Download Insider Trades to track AKTS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.5200 to $27.5100, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F2)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.5300 to $28.5000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F3)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.6300 to $28.7400, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F4)25% of the original number of shares subject to the option vested on July 1, 2025, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.